Compare PFBC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFBC | AMLX |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2021 |
| Metric | PFBC | AMLX |
|---|---|---|
| Price | $88.71 | $13.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $102.67 | $19.56 |
| AVG Volume (30 Days) | 67.6K | ★ 803.1K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $380,786,000.00 |
| Revenue This Year | $2.94 | N/A |
| Revenue Next Year | $8.31 | N/A |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $73.08 | $3.11 |
| 52 Week High | $103.05 | $17.49 |
| Indicator | PFBC | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 46.18 |
| Support Level | $80.74 | $13.28 |
| Resistance Level | $94.25 | $15.27 |
| Average True Range (ATR) | 2.53 | 0.93 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 40.43 | 10.53 |
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.